Just something to consider......
Recent CR and milestone payment leave Immutep in a strong financial position
should upon release of data prompt an offer of sorts for any part of Immuteps stable....
I know I harp on this but....recently awarded patents give potential suitors....viz Merck,
gives Merck the opportunity to extend their keytruda patent from expity date 2026 to
2034-2036.......Marc Voight is one smart cookie in my book, a bit ahead of the game....
Ann: Immutep to present data at upcoming Industry Conferences, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.015(5.17%) |
Mkt cap ! $447.2M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.5¢ | 29.0¢ | $942.5K | 3.123M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 169299 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 322439 | 33 |
View Market Depth
| Last trade - 15.49pm 11/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |